Creative Biolabs-Immuno-oncology

Anti-CD19 (clone FMC6Z3) SynExpress T7-G-I17-B Modified CD8+ T cells (CAT#: ITS-1224-CR933)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD19 (clone FMC6Z3). We employs the HBV (T7-GFP-IL-17-BamHI) vector components and the SynExpress system of the Single base pair Knock-in/Negative feedback for a robust and sustained response against cancers.
Host
Mouse
Target
CD19
Clone
FMC6Z3
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
GFP
Promoter
T7
Effector Gene
IL-17
Insertion Sites
BamHI
Gene Modification
Knock-in
Modification Domain
Single base pair
Carrier Type
HBV
Transformation Accuracy
0.9
Cell Culture
Aseptic Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.
Close
Thanksgiving
Thanksgiving